![Timothy Bailey MD, FACE, CPI](https://res.cloudinary.com/els-assets/image/upload/c_fill_pad,f_auto,g_auto,h_150,q_auto,w_120/v1/practice-update/remote-media/contentimage/26570.jpg)
Timothy S. Bailey MD, FACE, CPI
President and CEO, AMCR Institute, Escondido, California; Associate Professor of Medicine, University of California at San Diego, San Diego, CaliforniaDr. Bailey is the CEO and President of the AMCR Institute in Escondido, California and a clinical associate professor of medicine at the University of California at San Diego, where he helps to train endocrinology fellows. He is a past president of the California chapter and former board member of the American Association of Clinical Endocrinologists.
He has served as Principal Investigator on more than 200 phase 1 to 4 clinical trials testing new medications and technology for diabetes including sensors, delivery devices, and the "artificial pancreas". He has a particular interest in human factors testing and real-world trials, with the goal of improving adherence, persistence and the overall effectiveness of therapies for people with diabetes.
Disclosures
Dr. Bailey reports the following disclosures:- Research Support: Abbott, Capillary Biomedical , Dexcom, Diasome, Eli Lilly, Kowa, Lexicon, Medtronic, Medtrum, Novo Nordisk, REMD, Sanofi, Senseonics, Viacyte, vTv Therapeutics, Zealand Pharma
- Consulting Honoraria: Abbott, Lifescan, Novo, Sanofi
- Speaking Honoraria: Medtronic, Sanofi